FRASSOLDATI, ALESSIO
 Distribuzione geografica
Continente #
AS - Asia 178
NA - Nord America 108
EU - Europa 64
SA - Sud America 13
AF - Africa 10
Totale 373
Nazione #
US - Stati Uniti d'America 104
SG - Singapore 70
VN - Vietnam 53
CN - Cina 25
IT - Italia 19
HK - Hong Kong 11
SE - Svezia 10
DE - Germania 8
IN - India 8
GB - Regno Unito 7
BR - Brasile 6
FI - Finlandia 5
CI - Costa d'Avorio 4
IE - Irlanda 4
TG - Togo 4
CH - Svizzera 3
EC - Ecuador 3
FR - Francia 3
CA - Canada 2
JO - Giordania 2
JP - Giappone 2
KR - Corea 2
RU - Federazione Russa 2
AR - Argentina 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
CO - Colombia 1
GE - Georgia 1
JM - Giamaica 1
LT - Lituania 1
MX - Messico 1
NG - Nigeria 1
NL - Olanda 1
OM - Oman 1
PH - Filippine 1
TH - Thailandia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 373
Città #
Singapore 56
Chandler 17
Ashburn 15
Hanoi 13
Hong Kong 10
Ho Chi Minh City 9
San Jose 9
Bagnacavallo 6
Santa Clara 6
Beijing 5
Abidjan 4
Bologna 4
Dublin 4
Fairfield 4
Helsinki 4
Lomé 4
Southend 4
Bentivoglio 3
Boardman 3
Princeton 3
Redondo Beach 3
Amman 2
Bern 2
Guangzhou 2
Guayaquil 2
Nuremberg 2
Tokyo 2
Turin 2
Tân Tiến 2
Abeokuta 1
Bangkok 1
Berlin 1
Bexley 1
Bhopal 1
Bogotá 1
Bragado 1
Bremen 1
Bühl 1
Bắc Ninh 1
Bến Tre 1
Cajamar 1
Cambridge 1
Canoas 1
Chennai 1
Chicago 1
Cochabamba 1
Des Moines 1
Florence 1
Gunsan 1
Haiphong 1
Huizhou 1
Hưng Yên 1
Itabela 1
Jinan 1
Jining 1
Johannesburg 1
Kingston 1
La Joya de Los Sachas 1
Lappeenranta 1
Lauterbourg 1
Leawood 1
Leicester 1
Ludhiana 1
Muscat 1
Mérida 1
Nam Định 1
Nanyang 1
New York 1
North Bergen 1
Olalla 1
Osasco 1
Ottawa 1
Paulista 1
Portsmouth 1
Rach Gia 1
Raleigh 1
Redmond 1
Saint Louis 1
San Diego 1
San Francisco 1
Santiago 1
Seattle 1
Seoul 1
Shanwei 1
Shijiazhuang 1
Sofia 1
São Paulo 1
Tam Kỳ 1
Tampines New Town 1
Tashkent 1
Tbilisi 1
Thành Phố Bà Rịa 1
Tiền Giang 1
Toronto 1
Tuyên Quang 1
Venice 1
Washington 1
Wilmington 1
Xi'an 1
Xiamen 1
Totale 273
Nome #
Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) 155
null 99
Correction to: Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL) (British Journal of Cancer, (2020), 123, 1, (26-32), 10.1038/s41416-020-0845-3) 72
Erratum to: Survival prediction in high-grade gliomas using CT perfusion imaging [J Neurooncol (2015) 123, 93-102, DOI 10.1007/s11060-015-1766-5] 30
Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PET 27
Totale 383
Categoria #
all - tutte 1.192
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.192


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/202243 0 0 1 4 3 1 0 11 2 4 11 6
2022/202351 3 7 1 8 4 5 1 2 10 2 5 3
2023/202431 1 4 1 13 2 6 1 1 0 0 2 0
2024/202576 5 11 8 3 12 5 6 5 2 4 2 13
2025/2026177 11 4 8 13 34 7 13 8 61 18 0 0
Totale 383